MRS Awards And Recognitions
The MRS recognizes excellence in the field of metastasis by awarding the Paget-Ewing Award. The Paget-Ewing Award is named after Sir Stephen Paget and Dr. James Ewing, pioneers in metastasis research in the late 19th and early 20th centuries who proposed the two major theories to explain the organ selectivity of metastasis.
The Paget-Ewing Award is the highest honor bestowed by the Metastasis Research Society and honors a person's scientific excellence and substantial contributions to the understanding and/or control of cancer metastasis. Service to the MRS, or to the field in general, is not a primary criterion for the award. The award is open to all members of the metastasis research community apart from current members of the Board of Directors of the Metastasis Research Society and will be offered biennially.
|Paget-Ewing Award Recipients|
Fidler Innovation Award
The I.J. "Josh" Fidler Innovation in Metastasis Research Award acknowledges the special contributions of Dr. Fidler, who developed new models, shifted the manner in which metastasis is studied in experimental settings, contributed to our fundamental understanding of tumor progression and heterogeneity and translated laboratory findings into the clinical management of metastatic disease. The award is given to an investigator who has made innovative contributions to metastasis research, thereby influencing the direction -- either technically or conceptually -- of this area of research. The award is open to all members of the research community apart from current members of the Board of Directors of the Metastasis Research Society.
|Fidler innovation Award Recipients|
The Kurt Hellmann Award for the translation of metastasis research into clinical practice.
The renowned clinical pharmacologist Kurt Hellmann (1922-2013) was one of the founding fathers of the Metastasis Research Society and an early pioneer in the translation of basic metastasis research findings into clinical application. The Kurt Hellmann Award Lecture honors his outstanding contribution to the field. The award is given to an investigator who has contributed significantly to the translation of metastasis research into clinical practice. The award, sponsored by Novartis, is open to all members of the research community apart from current members of the Board of Directors of the Metastasis Research Society.
|Kurt Hellmann Award Recipients|
The Sue Eccles Young Investigator Award in Cancer Metastasis Research
The MRS board of directors established a Young Investigator Award in 2016 in honor of Dr. Sue Eccles, one of our most accomplished investigators and original supporter of the MRS. This award honors excellent metastasis research performed by members of the MRS who are 40 years old or less and has established his/her own research group. Eligible work for consideration should have been carried out after postdoctoral training and before tenure. Self-nomination is possible. Current members of the MRS board are not eligible.
|Sue Eccles Young Investigator Award Recipients|